Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Boshoff

Showing results (521-530 of 568) with videos related to

Pageof 57
Sort By:
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|February 28, 2025
Sanfetrinem, an oral β-lactam antibiotic repurposed for the treatment of tuberculosisSantiago Ramón-García, Rubén González Del Río, María Pilar Arenaz-Callao, et al.
Virulence|December 28, 2020
Tissue specific diversification, virulence and immune response to <i>Mycobacterium bovis</i> BCG in a patient with an IFN-γ R1 deficiencyCecilia B Korol, Shamira J Shallom, Kriti Arora, et al.
Bioorganic & Medicinal Chemistry|November 3, 2015
Aminopyrazolo[1,5-a]pyrimidines as potential inhibitors of Mycobacterium tuberculosis: Structure activity relationships and ADME characterizationCandice Soares de Melo, Soares de Melo Candice, Tzu-Shean Feng, et al.
ACS Infectious Diseases|January 18, 2019
Investigation of ( S)-(-)-Acidomycin: A Selective Antimycobacterial Natural Product That Inhibits Biotin SynthaseMatthew R Bockman, Curtis A Engelhart, Julia D Cramer, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|October 7, 2024
Long-term health outcomes of young patients with low-complexity coronary disease: a weighted analysis according to revascularization strategyPedro Custódio, Luís Garcez, Sérgio Madeira, et al.
Nature Communications|November 2, 2019
Plasticity of the Mycobacterium tuberculosis respiratory chain and its impact on tuberculosis drug developmentTiago Beites, Kathryn O'Brien, Divya Tiwari, et al.
Biorxiv : the Preprint Server for Biology|October 3, 2025
Structure-Guided Development of a Potent BioA Inhibitor Validates Biotin Synthesis Inhibition as a Therapeutic Strategy for TuberculosisQiang Liu, Joshua B Wallach, Yahani P Jayasinghe, et al.
Tuberculosis (Edinburgh, Scotland)|February 5, 2013
Updating and curating metabolic pathways of TBRichard A Slayden, Mary Jackson, Jeremy Zucker, et al.
The American Journal of Cardiology|December 19, 2018
Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention in Patients With Non-ST-Elevation Myocardial Infarction and Left Main or Multivessel Coronary DiseasePedro Freitas, Márcio Madeira, Luís Raposo, et al.
ACS Infectious Diseases|January 14, 2017
Structure-Activity Relationships of Spectinamide Antituberculosis Agents: A Dissection of Ribosomal Inhibition and Native Efflux Avoidance ContributionsJiuyu Liu, David F Bruhn, Robin B Lee, et al.
Pageof 57

Showing results (521-530 of 568) with videos related to

Sort By:
Pageof 57
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|February 28, 2025
Sanfetrinem, an oral β-lactam antibiotic repurposed for the treatment of tuberculosisSantiago Ramón-García, Rubén González Del Río, María Pilar Arenaz-Callao, et al.
Virulence|December 28, 2020
Tissue specific diversification, virulence and immune response to <i>Mycobacterium bovis</i> BCG in a patient with an IFN-γ R1 deficiencyCecilia B Korol, Shamira J Shallom, Kriti Arora, et al.
Bioorganic & Medicinal Chemistry|November 3, 2015
Aminopyrazolo[1,5-a]pyrimidines as potential inhibitors of Mycobacterium tuberculosis: Structure activity relationships and ADME characterizationCandice Soares de Melo, Soares de Melo Candice, Tzu-Shean Feng, et al.
ACS Infectious Diseases|January 18, 2019
Investigation of ( S)-(-)-Acidomycin: A Selective Antimycobacterial Natural Product That Inhibits Biotin SynthaseMatthew R Bockman, Curtis A Engelhart, Julia D Cramer, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|October 7, 2024
Long-term health outcomes of young patients with low-complexity coronary disease: a weighted analysis according to revascularization strategyPedro Custódio, Luís Garcez, Sérgio Madeira, et al.
Nature Communications|November 2, 2019
Plasticity of the Mycobacterium tuberculosis respiratory chain and its impact on tuberculosis drug developmentTiago Beites, Kathryn O'Brien, Divya Tiwari, et al.
Biorxiv : the Preprint Server for Biology|October 3, 2025
Structure-Guided Development of a Potent BioA Inhibitor Validates Biotin Synthesis Inhibition as a Therapeutic Strategy for TuberculosisQiang Liu, Joshua B Wallach, Yahani P Jayasinghe, et al.
Tuberculosis (Edinburgh, Scotland)|February 5, 2013
Updating and curating metabolic pathways of TBRichard A Slayden, Mary Jackson, Jeremy Zucker, et al.
The American Journal of Cardiology|December 19, 2018
Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention in Patients With Non-ST-Elevation Myocardial Infarction and Left Main or Multivessel Coronary DiseasePedro Freitas, Márcio Madeira, Luís Raposo, et al.
ACS Infectious Diseases|January 14, 2017
Structure-Activity Relationships of Spectinamide Antituberculosis Agents: A Dissection of Ribosomal Inhibition and Native Efflux Avoidance ContributionsJiuyu Liu, David F Bruhn, Robin B Lee, et al.
Pageof 57